Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$163K Buy
51,870
+7,144
+16% +$22.3K ﹤0.01% 2416
2026
Q1
$131K Buy
44,726
+17,336
+63% +$49.5K ﹤0.01% 2317
2025
Q4
$67.7K Buy
27,390
+7,590
+38% +$18.1K ﹤0.01% 2232
2025
Q3
$44.2K Sell
19,800
-363
-2% -$830 ﹤0.01% 2084
2025
Q2
$48.6K Buy
20,163
+7,220
+56% +$17.6K ﹤0.01% 1951
2025
Q1
$29.5K Buy
+12,943
New +$25.9K ﹤0.01% 1740

Other funds holding ABEV

&Partners's ABEV Position: Q2 2026 in Review

&Partners increased its Ambev (ABEV) stake by 16% in Q2 2026, buying an estimated $22.3K and bringing the position to 51,870 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #2416.

&Partners first reported a position in ABEV in Q1 2025 and has held it in 6 quarters since. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • &Partners held 51,870 shares of Ambev worth $163K as of Q2 2026.
  • &Partners bought 7,144 Ambev shares in Q2 2026, an estimated $22.3K.
  • Ambev made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #2416 holding.
  • &Partners first reported a position in Ambev in Q1 2025 and has held it in 6 quarters since.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.